FDA Releases Draft Guidance on Inclusion of Older Adults in Cancer Clinical Trials

Summary

The Food and Drug Administration (FDA) has released a draft guidance for the pharmaceutical industry on including older adults in cancer clinical trials, focusing on those aged 65 and above, particularly those over 75 years old, to better assess the safety and efficacy of cancer treatments in this demographic.